

Microdeletion Probes Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
The Microdeletion Probes market is experiencing robust growth, driven by increased genetic testing demand and rising awareness of genetic disorders. The market size is projected to reach approximately $400 million by 2028, with a compound annual growth rate (CAGR) of around 9%. Innovative technologies and increasing collaborations are enhancing market dynamics. Request Sample Report
◍ Abbott
◍ Cytocell
◍ Creative Bioarray
◍ Empire Genomics
◍ Leica Biosystems
◍ Oxford Gene Technology
The Microdeletion Probes Market features key players like Abbott, Cytocell, Creative Bioarray, Empire Genomics, Leica Biosystems, and Oxford Gene Technology. These companies enhance diagnostic capabilities and expand the market through innovative probe development, strategic partnerships, and comprehensive product offerings, driving sales growth and increasing accessibility to genomic testing solutions. Sales Revenue (actual figures where available):
- Abbott: $43 billion (2022)
- Cytocell: Specific figures not publicly disclosed
- Creative Bioarray: Specific figures not publicly disclosed
- Empire Genomics: Specific figures not publicly disclosed
- Leica Biosystems: Part of Danaher with $31.7 billion (2022)
- Oxford Gene Technology: Specific figures not publicly disclosed.
Request Sample Report
Cancers
Autoimmune Diseases
Other
Request Sample Report
Dual Color
Multi-color
Request Sample Report
$ X Billion USD